Publicacions (28) Publicacions de MARÍA PAZ SANZ AYÁN

2024

  1. Effects of Respiratory Muscle Training on Exercise Capacity, Quality of Life, and Respiratory and Pulmonary Function in People With Ischemic Heart Disease: Systematic Review and Meta-Analysis

    Physical Therapy, Vol. 104, Núm. 3

2023

  1. Eficacia de un programa de rehabilitación cardiaca en polideportivo municipal comparado con el programa hospitalario: ensayo controlado aleatorizado eCARCEX

    Anales del sistema sanitario de Navarra, Vol. 46, Núm. 3, pp. 11-20

  2. Intermittent hypoxic-hyperoxic conditioning for heart failure rehabilitation

    REC: CardioClinics, Vol. 58, Núm. 2, pp. 79-87

2022

  1. Adaptación de un Programa de Rehabilitación Cardíaca a un paciente con Amputación de Miembro Inferior. informe de un caso Adaptation of a Cardiac

    Scientific Medical Data

  2. Denosumab treatment for osteopenia or osteoporosis in heart transplant recipients: Effects and safety

    Transplantation Reports, Vol. 7, Núm. 3

2021

  1. Consensus on functional assessment of chronic pain in primary care: a Delphi study

    Current Medical Research and Opinion, Vol. 37, Núm. 12, pp. 2125-2132

  2. ESICM LIVES 2021: Part 2

    Intensive Care Medicine Experimental

  3. Quality of life and functional outcomes with tapentadol prolonged release in chronic musculoskeletal pain: <i>post hoc</i> analysis

    Pain Management, Vol. 11, Núm. 2, pp. 173-187

2018

  1. Health Benefits of an Innovative Exercise Program for Mitochondrial Disorders

    Medicine and Science in Sports and Exercise, Vol. 50, Núm. 6, pp. 1142-1151

  2. Physical activity levels are low in patients with pulmonary hypertension

    Annals of Translational Medicine, Vol. 6, Núm. 11, pp. 205-205

2017

  1. Benefits of skeletal-muscle exercise training in pulmonary arterial hypertension: The WHOLEi + 12 trial

    International Journal of Cardiology, Vol. 231, pp. 277-283

  2. Effects of an 8-month exercise intervention on physical capacity, NT-proBNP, physical activity levels and quality of life data in patients with pulmonary arterial hypertension by NYHA class

    Data in Brief

2016

  1. Efficacy of losartan vs. atenolol for the prevention of aortic dilation in Marfan syndrome: A randomized clinical trial

    European Heart Journal, Vol. 37, Núm. 12, pp. 978-985

  2. Exercise as an adjuvant therapy against chronic atrial fibrillation

    International Journal of Cardiology, Vol. 207, pp. 180-184

2015

  1. Predictive value of NT-proBNP combined with exercise capacity variables in pulmonary artery disease: Insights from a Spanish cohort

    International Journal of Cardiology, Vol. 186, pp. 32-34

  2. Rationale and Design of a Randomized Controlled Trial Evaluating Whole Muscle Exercise Training Effects in Outpatients with Pulmonary Arterial Hypertension (WHOLEi+12)

    Cardiovascular Drugs and Therapy, Vol. 29, Núm. 6, pp. 543-550

  3. The codification as tool in the clinic management of pain units

    Revista de la Sociedad Espanola del Dolor, Vol. 22, Núm. 4, pp. 145-158

2014

  1. Rehabilitación cardíaca infantil: trasplante cardíaco

    Rehabilitación infantil (Editorial Médica Panamericana), pp. 371-378

2011

  1. Ectasia dural y dolor lumbar en pacientes con síndrome de Marfan

    Trauma, Vol. 22, Núm. 4, pp. 248-255

  2. Ectasiadural y dolor lumbar en pacientes con sińdrome de marfan

    Trauma (Spain), Vol. 22, Núm. 4, pp. 248-255